Next 10 |
2024-04-16 21:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-07 00:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-19 06:53:51 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Abeona Therapeutics (NASDAQ: ABEO ) just reported results for the fourth quarter of 2023. Abeona Therapeutics reported earnings per share of -64 cents. This was below the ...
2024-03-18 10:00:18 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Johnson & Johnson, Boston...
2024-03-18 07:41:37 ET More on Abeona Therapeutics Abeona issues update on FDA market application for pz-cel Abeona Therapeutics announces $50M credit facility Seeking Alpha’s Quant Rating on Abeona Therapeutics Historical earnings data for Abeona Ther...
CLEVELAND, March 18, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the full year of 2023 and provided an update on progress toward achieving key corporate objectives. Abeona also announced today that the U.S. Food and Drug Administrati...
2024-02-07 10:31:12 ET More on Abeona Therapeutics Abeona issues update on FDA market application for pz-cel Abeona Therapeutics announces $50M credit facility Seeking Alpha’s Quant Rating on Abeona Therapeutics Historical earnings data for Abeona Ther...
2024-02-01 11:48:30 ET More on Abeona Therapeutics Abeona Therapeutics Inc. (ABEO) Q3 2023 Earnings Call Transcript Abeona Therapeutics announces $50M credit facility Abeona shares jump after FDA priority review for epidermolysis bullosa drug Seeking Alpha...
- On track for PDUFA target action date of May 25, 2024 - CLEVELAND, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced, as part of the review process by the U.S. Food and Drug Administration (FDA) for the Biologics License Application (BLA) for pz-c...
2024-01-08 07:54:50 ET More on Abeona Therapeutics Abeona Therapeutics Inc. (ABEO) Q3 2023 Earnings Call Transcript Abeona shares jump after FDA priority review for epidermolysis bullosa drug Abeona Therapeutics GAAP EPS of -$0.48 beats by $0.05 Seeking Alpha...
News, Short Squeeze, Breakout and More Instantly...
Abeona Therapeutics Inc. Company Name:
ABEO Stock Symbol:
NASDAQ Market:
Abeona Therapeutics Inc. Website:
2024-04-16 21:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-07 00:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...